HCG-M S Ramaiah Cancer Centre, a unit of Healthcare Global Enterprise, launched the first ‘Agility Synergy’ in India, an advanced radiotherapy technology, inaugurated by Professor CNR Rao. Agility is a multileaf collimator (MLC) manufactured by Swedish medical equipment company Elekta.
Professor Rao, on the inauguration of the technology, said, “It gives me immense pleasure to inaugurate the first “Agility Synergy” in India. Research and technology has played a very crucial role in the advances in cancer treatment. I’m pleased to know the gold standard in precision cancer treatment is now accessible in India.”
Dr BS Ajaikumar, Chairman, HCG Enterprise, said, “HCG has been at the forefront in the fight against cancer by introducing new technologies and improving medical outcomes. With the introduction of Agility – Synergy, for the first time in India, patients will immensely benefit from the most precise cancer care treatment available.”
Reportedly, the benefits of Agility Synergy are as follows:
- Increases the speed of delivery and allows higher dose rates to be used for more effective modulation
- Shortens treatment times considerably
- Continuous monitoring and control throughout treatment for confidence in beam shaping and treatment delivery
- It reduces unwanted dose to organs at risk and healthy tissue
- It reduces off axis dose when performing off-axis beam shaping
- Low integral dose reduces the risk of inducing secondary tumours.
EH News Bureau